UNCY
Unicycive Therapeutics Inc. Common Stock
$0.638+0.000 (0.000%)
Reaalajas hind
Hinnagraafik
Loading Chart...
Põhinäitajad
Turunäitajad
Avatud
$0.638
Kõrge
$0.638
Madal
$0.638
Maht
4.18M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
GlobeNewswire
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10,
Vaata rohkem
Analyst Upgrades
HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Unicycive Therapeutics with a Buy rating and announces Price Target of $9.
Vaata rohkem
GlobeNewswire
Unicycive Therapeutics to Present at Upcoming Investor Conferences
LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh
Vaata rohkem
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.